Intuitive surgical, inc.
ISRG 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分中等，已經有部位可以持續持有，若想建立新部位可以等待價值評分轉變為4分以上、股利提升為2分以上
ISRG 近期報酬表現
0.59%
Intuitive surgical, inc.
6.23%
同產業平均
1.02%
S&P500
與 ISRG 同產業的標的表現
| 股票代碼 | 公司名稱 | 價值 | 趨勢 | 波段 | 籌碼 | 股利 | 加入追蹤 |
|---|---|---|---|---|---|---|---|
IDXX | Idexx laboratories incorporated | 4 分 | 1 分 | 4 分 | 2 分 | 1 分 | |
SYK | Stryker corporation | 3 分 | 3 分 | 2 分 | 3 分 | 4 分 | |
ATRC | Atricure inc | 2 分 | 1 分 | 2 分 | 3 分 | 1 分 | |
COO | Cooper companies inc | 4 分 | 3 分 | 1 分 | 3 分 | 3 分 | |
BSX | Boston scientific corporation | 4 分 | 5 分 | 4 分 | 2 分 | 1 分 |
- IDXX Idexx laboratories incorporated價值 4 分趨勢 1 分波段 4 分籌碼 2 分股利 1 分查看更多
ISRG 公司資訊
Intuitive Surgical, Inc. develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system. The Company's products and related services enable physicians and healthcare providers to access minimally invasive care. The da Vinci surgical system consists of a surgeon console or consoles, a patient-side cart, and a high-performance vision system. The da Vinci products fall into five categories, namely da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. It also provides a comprehensive suite of systems, learning, and services offerings. The Ion endoluminal system consists of a system cart, a controller, a catheter, and a vision probe. It extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Both systems use software, instruments, and accessories.